Polymyalgia rheumatica (PMR), Giant cell arteritis (GCA) research hub

Study to evaluate the pharmacokinetics, safety and tolerability of Secukinumab in patients with GCA or PMR

This study is looking at a medicine called Secukinumab for people with two conditions: polymyalgia rheumatica (PMR) or giant cell arteritis (GCA). It aims to understand how the medicine works in the body and if it's safe at an early stage.